Dr. Krystal Ann Ozanick is a Alameda, California based psychiatrist who is specialized in Child & Adolescent. Active license number of Dr. Krystal Ann Ozanick is DR.0070308 for Child & Adolescent in Colorado. Her current practice location is 1005 Atlantic Ave, Alameda. Patients can reach her at 415-474-7310. Dr. Krystal Ann Ozanick is M.D. in Child & Adolescent and her NPI number (Unique professional ID assigned by NPPES) is 1841580032. Dr. Krystal Ann Ozanick has done additional skills and training in the diagnosis and treatment of developmental, behavioral, emotional, and mental disorders of childhood and adolescence.
Complete Profile:
Dr. Krystal Ann Ozanick speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1841580032
NPI Enumeration Date:
09 Apr, 2011
NPI Last Update On:
11 Apr, 2023
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Krystal Ann Ozanick are as mentioned below.
License Number
Specialization
State
Status
DR.0070308
Child & Adolescent
Colorado
Primary
A131159
Child & Adolescent
California
Secondary
249117
Child & Adolescent
Massachusetts
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. Krystal Ann Ozanick Po Box 110429, Aurora, Colorado
Zip:
80042-0429
Patients can reach Dr. Krystal Ann Ozanick at 1005 Atlantic Ave, Alameda, California or can call to book an appointment on 415-474-7310.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.